Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Wolfe Research's Rating of CG Oncology on 5/19/2026

On May 19, 2026, Wolfe Research updated its outlook on CG Oncology (NASDAQ:CGON) with the action "Initiated Coverage", setting a "Peer Perform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.